EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 100 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $18,044 | -22.4% | 20,118 | +2.0% | 0.00% | – |
Q4 2022 | $23,267 | -84.4% | 19,718 | -0.4% | 0.00% | -100.0% |
Q3 2022 | $149,000 | +23.1% | 19,790 | +3.2% | 0.00% | 0.0% |
Q2 2022 | $121,000 | -8.3% | 19,177 | +20.7% | 0.00% | 0.0% |
Q1 2022 | $132,000 | +50.0% | 15,894 | -6.6% | 0.00% | – |
Q4 2021 | $88,000 | -24.8% | 17,012 | -2.9% | 0.00% | -100.0% |
Q3 2021 | $117,000 | -23.5% | 17,522 | -2.3% | 0.00% | 0.0% |
Q2 2021 | $153,000 | -3.2% | 17,939 | +0.6% | 0.00% | 0.0% |
Q1 2021 | $158,000 | -27.9% | 17,829 | +0.3% | 0.00% | 0.0% |
Q4 2020 | $219,000 | +63.4% | 17,781 | +8.1% | 0.00% | 0.0% |
Q3 2020 | $134,000 | -2.9% | 16,443 | +14.1% | 0.00% | 0.0% |
Q2 2020 | $138,000 | +46.8% | 14,409 | +3.8% | 0.00% | 0.0% |
Q1 2020 | $94,000 | -57.1% | 13,877 | -5.5% | 0.00% | 0.0% |
Q4 2019 | $219,000 | +44.1% | 14,678 | -0.8% | 0.00% | 0.0% |
Q3 2019 | $152,000 | -3.8% | 14,802 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $158,000 | +532.0% | 14,905 | +589.7% | 0.00% | – |
Q1 2017 | $25,000 | +8.7% | 2,161 | +8.6% | 0.00% | – |
Q4 2016 | $23,000 | -99.9% | 1,990 | -0.3% | 0.00% | – |
Q3 2016 | $26,726,000 | -32.3% | 1,996 | +0.2% | 0.00% | – |
Q2 2016 | $39,501,000 | – | 1,993 | +15230.8% | 0.00% | – |
Q1 2016 | $0 | – | 13 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |